108 related articles for article (PubMed ID: 27671230)
1. Prognosis of Medullary Carcinoma of the Breast: 10 years' Experience in a Single Institution.
Kouhen F; Benhmidou N; Afif M; Rais F; Khamou M; Khanoussi B; El Menaoui O; Elkacemi H; Elmajjaoui S; Kebdani T; Benjaafar N
Breast J; 2017 Jan; 23(1):112-114. PubMed ID: 27671230
[No Abstract] [Full Text] [Related]
2. Atypical medullary carcinoma of the breast has similar prognostic factors and survival to typical medullary breast carcinoma: 3,976 cases from the National Cancer Data Base.
Mateo AM; Pezzi TA; Sundermeyer M; Kelley CA; Klimberg VS; Pezzi CM
J Surg Oncol; 2016 Oct; 114(5):533-536. PubMed ID: 27393599
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials.
Huober J; Gelber S; Goldhirsch A; Coates AS; Viale G; Öhlschlegel C; Price KN; Gelber RD; Regan MM; Thürlimann B
Ann Oncol; 2012 Nov; 23(11):2843-2851. PubMed ID: 22707751
[TBL] [Abstract][Full Text] [Related]
4. Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases.
Reinfuss M; Stelmach A; Mitus J; Rys J; Duda K
J Surg Oncol; 1995 Oct; 60(2):89-94. PubMed ID: 7564387
[TBL] [Abstract][Full Text] [Related]
5. Medullary carcinoma of the breast.
Pedersen L
APMIS Suppl; 1997; 75():1-31. PubMed ID: 9439575
[No Abstract] [Full Text] [Related]
6. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma.
Thurman SA; Schnitt SJ; Connolly JL; Gelman R; Silver B; Harris JR; Recht A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):152-9. PubMed ID: 15093911
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
8. Medullary carcinoma of the breast: ten year clinical experience of the Kuwait cancer control centre.
Samir SM; Fayaz MS; Elbasmi A; Motawy MM; Abuzallouf S; George T; Abdelhady M; Bedair A
Gulf J Oncolog; 2011 Jul; (10):45-52. PubMed ID: 21724529
[TBL] [Abstract][Full Text] [Related]
9. Medullary thyroid carcinoma in Hong Kong Chinese patients.
Chow SM; Chan JK; Tiu SC; Choi KL; Tang DL; Law SC
Hong Kong Med J; 2005 Aug; 11(4):251-8. PubMed ID: 16085941
[TBL] [Abstract][Full Text] [Related]
10. Novel prognostic markers for patients with triple-negative breast cancer.
Zhou L; Li K; Luo Y; Tian L; Wang M; Li C; Huang Q
Hum Pathol; 2013 Oct; 44(10):2180-7. PubMed ID: 23845466
[TBL] [Abstract][Full Text] [Related]
11. Synchronous bilateral medullary carcinoma of breast: is it metastasis or second primary?
; Permi HS; Kishan Prasad HL; Mohan R; Shetty KJ; Patil C
J Cancer Res Ther; 2012; 8(1):129-31. PubMed ID: 22531532
[TBL] [Abstract][Full Text] [Related]
12. Medullary carcinoma of the breast: a brief report from a tertiary care center.
Altundag K; Roach EC; Kizilarslanoglu MC
J BUON; 2012; 17(1):185. PubMed ID: 22517716
[No Abstract] [Full Text] [Related]
13. [Characteristics and prognostic factors of postoperative chemotherapy for female breast cancer patients under 30 years of age: a report of 129 patients].
Wang ZH; Xu BH
Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):111-3. PubMed ID: 15946553
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of medullary carcinoma of the breast].
Li XX; Wang SM; Lai YH; Li SQ
Zhonghua Wai Ke Za Zhi; 2005 Dec; 43(23):1516-8. PubMed ID: 16412287
[TBL] [Abstract][Full Text] [Related]
15. Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer.
Grönberg M; Fjällskog ML; Jirström K; Janson ET
Acta Oncol; 2012 Mar; 51(3):386-93. PubMed ID: 22067021
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer in very young women.
Liukkonen S; Leidenius M; Saarto T; Sjöström-Mattson J
Eur J Surg Oncol; 2011 Dec; 37(12):1030-7. PubMed ID: 21937191
[TBL] [Abstract][Full Text] [Related]
17. The significance of lymph node involvement in patients with medullary carcinoma of the breast.
Black CL; Morris DM; Goldman LI; McDonald JC
Surg Gynecol Obstet; 1983 Dec; 157(6):497-9. PubMed ID: 6648768
[TBL] [Abstract][Full Text] [Related]
18. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
Hatoum HA; Jamali FR; El-Saghir NS; Musallam KM; Seoud M; Dimassi H; Abbas J; Khalife M; Boulos FI; Tawil AN; Geara FB; Salem Z; Shamseddine AA; Al-Feghali K; Shamseddine AI
Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma.
Lê MG; Arriagada R; Spielmann M; Guinebretière JM; Rochard F
Cancer; 2002 Jun; 94(11):2813-20. PubMed ID: 12115367
[TBL] [Abstract][Full Text] [Related]
20. [Medullary carcinoma of the breast. What remains of this entity today?].
Contesso G; Rapin-Marion V; Mouriesse H
Arch Anat Cytol Pathol; 1995; 43(1-2):44-50. PubMed ID: 7794026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
